Covid-19 Clinical Trial
Official title:
Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19
Coronavirus infection is responsible for muscle wasting (sarcopenia), especially during
prolonged stays in intensive care. Sarcopenia, in its functional aspect also seems major in
patients hospitalized for this infection, in non-ICU unit. Weight loss also appears to be
significant, despite a prevalence of overweight and obesity in severe forms. Undernutrition
in the obese patient is also possible (undernourished obese and sarcopenia obesity). Anosmia
and dysgeusia participate in undernutrition by reducing energy intake. The rehabilitation of
these patients requires nutritional support (increased protein intake) associated with
progressive retraining to physical activity.
An early and proactive management procedure within Coronavirus disease-19 units has been
implemented in conjunction with the Transversal Nutrition Unit (TNU). This nutritional care
must be continued after discharge. Follow-up by teleconsultation or telephone consultation is
put in place after the patient's discharge Primary Objective: Evaluation of nutritional
status at the time of admission and discharge and home follow-up in outgoing patients from
Coronavirus disease-19 Units Secondary objectives: Description of the evolution of food
intake, diversity of food and coverage of needs Evaluation of the muscular strength of the
wrist (by grip test in hospital) and on the arms and legs after return home (visual analog
scale) Evolution of anosmia and dysgeusia (at the time of hospital admission, at the time of
hospital discharge and at home) Level of physical training before infection (IPAQ)
Description of the general state of health measured by the performance index - world health
organization scale Description of nutritional prescriptions Description of the prevention
measures and incidence of Inappropriate Refeeding Syndrome (IRS) Care needs assessments
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|